Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback